Nordson Corporation (NDSN) has seen a recent 10% drop with trimmed sales and earnings guidance. Analyst opinion is divided as to whether the dividend aristocrat stock is undervalued or needs to be avoided. Q2 results showed lower profit and flat sales, which along with other factors have led to Nordson's return hitting a wall. Nordson's acquisition of Atrion for $800 million is expected to boost its medical offerings. Institutional investors make up 75% of the company shareholders, while the appointment of a new CFO occurred amid a downgrade of growth forecasts. Q2 earnings missed the estimates with some forecasts dropping. However, the company remains a choice for its strong fundamentals with potential for stocks to explode this quarter. Nordson closed an $800 million deal to acquire Atrion and plans to acquire the ARAG Group for $1 billion. A potential setback was the stock's 12.8% drop and lower Q3 earnings predictions. Nordson completed acquisitions of CyberOptics Corporation and NDC Technologies, while purchasing Fluortek to enhance its medical tubing components. Amid varied predictions, their earnings surprise streak may persist.
Nordson Corp NDSN News Analytics from Thu, 11 Aug 2016 19:09:01 GMT to Fri, 07 Jun 2024 22:02:31 GMT -
Rating 1
- Innovation 2
- Information 7
- Rumor 0
